0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cattle and Sheep Routine Vaccine Market Research Report 2026
Published Date: 2026-04-15
|
Report Code: QYRE-Auto-22A17050
Home | Market Reports | Law & Government| Public Safety
Global Cattle and Sheep Routine Vaccine Market Research Report 2024
BUY CHAPTERS

Global Cattle and Sheep Routine Vaccine Market Research Report 2026

Code: QYRE-Auto-22A17050
Report
2026-04-15
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cattle and Sheep Routine Vaccine Market

The global Cattle and Sheep Routine Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cattle and Sheep Routine Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Routine vaccination programs for cattle and sheep are essential for maintaining herd health, preventing disease outbreaks, and optimizing production in livestock operations. The specific vaccines administered to cattle and sheep may vary based on factors such as geographic location, herd size, management practices, and disease prevalence.
The North American market for Cattle and Sheep Routine Vaccine is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cattle and Sheep Routine Vaccine is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Cattle and Sheep Routine Vaccine include Boehringer Ingelheim International GmbH, Zoetis, Inc., Merck & Co., Inc., Bimeda, Inc., Elanco Animal Health, Inc., Virbac, Ceva Sante Animale, CZ Vaccines S.A.U., Indian Immunologicals Ltd., Vaxxinova International BV (EW Group), etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cattle and Sheep Routine Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cattle and Sheep Routine Vaccine. The Cattle and Sheep Routine Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cattle and Sheep Routine Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cattle and Sheep Routine Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Cattle and Sheep Routine Vaccine Market Report

Report Metric Details
Report Name Cattle and Sheep Routine Vaccine Market
Segment by Type
  • Modified/ Attenuated Live Vaccines
  • Inactivated (Killed) Vaccines
  • Others
by Application
  • Cattle
  • Sheep & Goats
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim International GmbH, Zoetis, Inc., Merck & Co., Inc., Bimeda, Inc., Elanco Animal Health, Inc., Virbac, Ceva Sante Animale, CZ Vaccines S.A.U., Indian Immunologicals Ltd., Vaxxinova International BV (EW Group), Jinyu Bio-Technology, CNBG, China Animal Husbandry Industry Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Cattle and Sheep Routine Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Cattle and Sheep Routine Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Cattle and Sheep Routine Vaccine Market report?

Ans: The main players in the Cattle and Sheep Routine Vaccine Market are Boehringer Ingelheim International GmbH, Zoetis, Inc., Merck & Co., Inc., Bimeda, Inc., Elanco Animal Health, Inc., Virbac, Ceva Sante Animale, CZ Vaccines S.A.U., Indian Immunologicals Ltd., Vaxxinova International BV (EW Group), Jinyu Bio-Technology, CNBG, China Animal Husbandry Industry Co., Ltd.

What are the Application segmentation covered in the Cattle and Sheep Routine Vaccine Market report?

Ans: The Applications covered in the Cattle and Sheep Routine Vaccine Market report are Cattle, Sheep & Goats

What are the Type segmentation covered in the Cattle and Sheep Routine Vaccine Market report?

Ans: The Types covered in the Cattle and Sheep Routine Vaccine Market report are Modified/ Attenuated Live Vaccines, Inactivated (Killed) Vaccines, Others

1 Cattle and Sheep Routine Vaccine Market Overview
1.1 Product Definition
1.2 Cattle and Sheep Routine Vaccine by Type
1.2.1 Global Cattle and Sheep Routine Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Modified/ Attenuated Live Vaccines
1.2.3 Inactivated (Killed) Vaccines
1.2.4 Others
1.3 Cattle and Sheep Routine Vaccine by Application
1.3.1 Global Cattle and Sheep Routine Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Cattle
1.3.3 Sheep & Goats
1.4 Global Cattle and Sheep Routine Vaccine Market Size Estimates and Forecasts
1.4.1 Global Cattle and Sheep Routine Vaccine Revenue 2021–2032
1.4.2 Global Cattle and Sheep Routine Vaccine Sales 2021–2032
1.4.3 Global Cattle and Sheep Routine Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Cattle and Sheep Routine Vaccine Market Competition by Manufacturers
2.1 Global Cattle and Sheep Routine Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cattle and Sheep Routine Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cattle and Sheep Routine Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cattle and Sheep Routine Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Date of Entry into the Industry
2.8 Global Cattle and Sheep Routine Vaccine Market Competitive Situation and Trends
2.8.1 Global Cattle and Sheep Routine Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cattle and Sheep Routine Vaccine Players Market Share by Revenue
2.8.3 Global Cattle and Sheep Routine Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cattle and Sheep Routine Vaccine Market Scenario by Region
3.1 Global Cattle and Sheep Routine Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cattle and Sheep Routine Vaccine Sales by Region: 2021–2032
3.2.1 Global Cattle and Sheep Routine Vaccine Sales by Region: 2021–2026
3.2.2 Global Cattle and Sheep Routine Vaccine Sales by Region: 2027–2032
3.3 Global Cattle and Sheep Routine Vaccine Revenue by Region: 2021–2032
3.3.1 Global Cattle and Sheep Routine Vaccine Revenue by Region: 2021–2026
3.3.2 Global Cattle and Sheep Routine Vaccine Revenue by Region: 2027–2032
3.4 North America Cattle and Sheep Routine Vaccine Market Facts & Figures by Country
3.4.1 North America Cattle and Sheep Routine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cattle and Sheep Routine Vaccine Sales by Country (2021–2032)
3.4.3 North America Cattle and Sheep Routine Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cattle and Sheep Routine Vaccine Market Facts & Figures by Country
3.5.1 Europe Cattle and Sheep Routine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cattle and Sheep Routine Vaccine Sales by Country (2021–2032)
3.5.3 Europe Cattle and Sheep Routine Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cattle and Sheep Routine Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Cattle and Sheep Routine Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cattle and Sheep Routine Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Cattle and Sheep Routine Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cattle and Sheep Routine Vaccine Market Facts & Figures by Country
3.7.1 Latin America Cattle and Sheep Routine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cattle and Sheep Routine Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Cattle and Sheep Routine Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cattle and Sheep Routine Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Cattle and Sheep Routine Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cattle and Sheep Routine Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cattle and Sheep Routine Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cattle and Sheep Routine Vaccine Sales by Type (2021–2032)
4.1.1 Global Cattle and Sheep Routine Vaccine Sales by Type (2021–2026)
4.1.2 Global Cattle and Sheep Routine Vaccine Sales by Type (2027–2032)
4.1.3 Global Cattle and Sheep Routine Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Cattle and Sheep Routine Vaccine Revenue by Type (2021–2032)
4.2.1 Global Cattle and Sheep Routine Vaccine Revenue by Type (2021–2026)
4.2.2 Global Cattle and Sheep Routine Vaccine Revenue by Type (2027–2032)
4.2.3 Global Cattle and Sheep Routine Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Cattle and Sheep Routine Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Cattle and Sheep Routine Vaccine Sales by Application (2021–2032)
5.1.1 Global Cattle and Sheep Routine Vaccine Sales by Application (2021–2026)
5.1.2 Global Cattle and Sheep Routine Vaccine Sales by Application (2027–2032)
5.1.3 Global Cattle and Sheep Routine Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Cattle and Sheep Routine Vaccine Revenue by Application (2021–2032)
5.2.1 Global Cattle and Sheep Routine Vaccine Revenue by Application (2021–2026)
5.2.2 Global Cattle and Sheep Routine Vaccine Revenue by Application (2027–2032)
5.2.3 Global Cattle and Sheep Routine Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Cattle and Sheep Routine Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boehringer Ingelheim International GmbH
6.1.1 Boehringer Ingelheim International GmbH Company Information
6.1.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.1.3 Boehringer Ingelheim International GmbH Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boehringer Ingelheim International GmbH Cattle and Sheep Routine Vaccine Product Portfolio
6.1.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.2 Zoetis, Inc.
6.2.1 Zoetis, Inc. Company Information
6.2.2 Zoetis, Inc. Description and Business Overview
6.2.3 Zoetis, Inc. Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Zoetis, Inc. Cattle and Sheep Routine Vaccine Product Portfolio
6.2.5 Zoetis, Inc. Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Company Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merck & Co., Inc. Cattle and Sheep Routine Vaccine Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Bimeda, Inc.
6.4.1 Bimeda, Inc. Company Information
6.4.2 Bimeda, Inc. Description and Business Overview
6.4.3 Bimeda, Inc. Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bimeda, Inc. Cattle and Sheep Routine Vaccine Product Portfolio
6.4.5 Bimeda, Inc. Recent Developments/Updates
6.5 Elanco Animal Health, Inc.
6.5.1 Elanco Animal Health, Inc. Company Information
6.5.2 Elanco Animal Health, Inc. Description and Business Overview
6.5.3 Elanco Animal Health, Inc. Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Elanco Animal Health, Inc. Cattle and Sheep Routine Vaccine Product Portfolio
6.5.5 Elanco Animal Health, Inc. Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Company Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Virbac Cattle and Sheep Routine Vaccine Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Ceva Sante Animale
6.7.1 Ceva Sante Animale Company Information
6.7.2 Ceva Sante Animale Description and Business Overview
6.7.3 Ceva Sante Animale Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ceva Sante Animale Cattle and Sheep Routine Vaccine Product Portfolio
6.7.5 Ceva Sante Animale Recent Developments/Updates
6.8 CZ Vaccines S.A.U.
6.8.1 CZ Vaccines S.A.U. Company Information
6.8.2 CZ Vaccines S.A.U. Description and Business Overview
6.8.3 CZ Vaccines S.A.U. Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CZ Vaccines S.A.U. Cattle and Sheep Routine Vaccine Product Portfolio
6.8.5 CZ Vaccines S.A.U. Recent Developments/Updates
6.9 Indian Immunologicals Ltd.
6.9.1 Indian Immunologicals Ltd. Company Information
6.9.2 Indian Immunologicals Ltd. Description and Business Overview
6.9.3 Indian Immunologicals Ltd. Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Indian Immunologicals Ltd. Cattle and Sheep Routine Vaccine Product Portfolio
6.9.5 Indian Immunologicals Ltd. Recent Developments/Updates
6.10 Vaxxinova International BV (EW Group)
6.10.1 Vaxxinova International BV (EW Group) Company Information
6.10.2 Vaxxinova International BV (EW Group) Description and Business Overview
6.10.3 Vaxxinova International BV (EW Group) Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Vaxxinova International BV (EW Group) Cattle and Sheep Routine Vaccine Product Portfolio
6.10.5 Vaxxinova International BV (EW Group) Recent Developments/Updates
6.11 Jinyu Bio-Technology
6.11.1 Jinyu Bio-Technology Company Information
6.11.2 Jinyu Bio-Technology Description and Business Overview
6.11.3 Jinyu Bio-Technology Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jinyu Bio-Technology Cattle and Sheep Routine Vaccine Product Portfolio
6.11.5 Jinyu Bio-Technology Recent Developments/Updates
6.12 CNBG
6.12.1 CNBG Company Information
6.12.2 CNBG Description and Business Overview
6.12.3 CNBG Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 CNBG Cattle and Sheep Routine Vaccine Product Portfolio
6.12.5 CNBG Recent Developments/Updates
6.13 China Animal Husbandry Industry Co., Ltd.
6.13.1 China Animal Husbandry Industry Co., Ltd. Company Information
6.13.2 China Animal Husbandry Industry Co., Ltd. Description and Business Overview
6.13.3 China Animal Husbandry Industry Co., Ltd. Cattle and Sheep Routine Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 China Animal Husbandry Industry Co., Ltd. Cattle and Sheep Routine Vaccine Product Portfolio
6.13.5 China Animal Husbandry Industry Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cattle and Sheep Routine Vaccine Industry Chain Analysis
7.2 Cattle and Sheep Routine Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cattle and Sheep Routine Vaccine Production Mode & Process Analysis
7.4 Cattle and Sheep Routine Vaccine Sales and Marketing
7.4.1 Cattle and Sheep Routine Vaccine Sales Channels
7.4.2 Cattle and Sheep Routine Vaccine Distributors
7.5 Cattle and Sheep Routine Vaccine Customer Analysis
8 Cattle and Sheep Routine Vaccine Market Dynamics
8.1 Cattle and Sheep Routine Vaccine Industry Trends
8.2 Cattle and Sheep Routine Vaccine Market Drivers
8.3 Cattle and Sheep Routine Vaccine Market Challenges
8.4 Cattle and Sheep Routine Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Cattle and Sheep Routine Vaccine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Cattle and Sheep Routine Vaccine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Cattle and Sheep Routine Vaccine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Cattle and Sheep Routine Vaccine Sales (K Dose) of Key Manufacturers (2021–2026)
 Table 5. Global Cattle and Sheep Routine Vaccine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Cattle and Sheep Routine Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Cattle and Sheep Routine Vaccine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Cattle and Sheep Routine Vaccine Average Price (US$/Dose) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Cattle and Sheep Routine Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Product Types and Applications
 Table 12. Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cattle and Sheep Routine Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cattle and Sheep Routine Vaccine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cattle and Sheep Routine Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Cattle and Sheep Routine Vaccine Sales by Region (K Dose), 2021–2026
 Table 18. Global Cattle and Sheep Routine Vaccine Sales Market Share by Region (2021–2026)
 Table 19. Global Cattle and Sheep Routine Vaccine Sales by Region (K Dose), 2027–2032
 Table 20. Global Cattle and Sheep Routine Vaccine Sales Market Share by Region (2027–2032)
 Table 21. Global Cattle and Sheep Routine Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Region (2021–2026)
 Table 23. Global Cattle and Sheep Routine Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Region (2027–2032)
 Table 25. North America Cattle and Sheep Routine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Cattle and Sheep Routine Vaccine Sales by Country (K Dose), 2021–2026
 Table 27. North America Cattle and Sheep Routine Vaccine Sales by Country (K Dose), 2027–2032
 Table 28. North America Cattle and Sheep Routine Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Cattle and Sheep Routine Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Cattle and Sheep Routine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Cattle and Sheep Routine Vaccine Sales by Country (K Dose), 2021–2026
 Table 32. Europe Cattle and Sheep Routine Vaccine Sales by Country (K Dose), 2027–2032
 Table 33. Europe Cattle and Sheep Routine Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Cattle and Sheep Routine Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Cattle and Sheep Routine Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Cattle and Sheep Routine Vaccine Sales by Region (K Dose), 2021–2026
 Table 37. Asia Pacific Cattle and Sheep Routine Vaccine Sales by Region (K Dose), 2027–2032
 Table 38. Asia Pacific Cattle and Sheep Routine Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Cattle and Sheep Routine Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Cattle and Sheep Routine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Cattle and Sheep Routine Vaccine Sales by Country (K Dose), 2021–2026
 Table 42. Latin America Cattle and Sheep Routine Vaccine Sales by Country (K Dose), 2027–2032
 Table 43. Latin America Cattle and Sheep Routine Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Cattle and Sheep Routine Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Cattle and Sheep Routine Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Cattle and Sheep Routine Vaccine Sales by Country (K Dose), 2021–2026
 Table 47. Middle East and Africa Cattle and Sheep Routine Vaccine Sales by Country (K Dose), 2027–2032
 Table 48. Middle East and Africa Cattle and Sheep Routine Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Cattle and Sheep Routine Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Cattle and Sheep Routine Vaccine Sales (K Dose) by Type (2021–2026)
 Table 51. Global Cattle and Sheep Routine Vaccine Sales (K Dose) by Type (2027–2032)
 Table 52. Global Cattle and Sheep Routine Vaccine Sales Market Share by Type (2021–2026)
 Table 53. Global Cattle and Sheep Routine Vaccine Sales Market Share by Type (2027–2032)
 Table 54. Global Cattle and Sheep Routine Vaccine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Cattle and Sheep Routine Vaccine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Type (2021–2026)
 Table 57. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Type (2027–2032)
 Table 58. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Type (2021–2026)
 Table 59. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Type (2027–2032)
 Table 60. Global Cattle and Sheep Routine Vaccine Sales (K Dose) by Application (2021–2026)
 Table 61. Global Cattle and Sheep Routine Vaccine Sales (K Dose) by Application (2027–2032)
 Table 62. Global Cattle and Sheep Routine Vaccine Sales Market Share by Application (2021–2026)
 Table 63. Global Cattle and Sheep Routine Vaccine Sales Market Share by Application (2027–2032)
 Table 64. Global Cattle and Sheep Routine Vaccine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Cattle and Sheep Routine Vaccine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Application (2021–2026)
 Table 67. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Application (2027–2032)
 Table 68. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Application (2021–2026)
 Table 69. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Application (2027–2032)
 Table 70. Boehringer Ingelheim International GmbH Company Information
 Table 71. Boehringer Ingelheim International GmbH Description and Business Overview
 Table 72. Boehringer Ingelheim International GmbH Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 73. Boehringer Ingelheim International GmbH Cattle and Sheep Routine Vaccine Product
 Table 74. Boehringer Ingelheim International GmbH Recent Developments/Updates
 Table 75. Zoetis, Inc. Company Information
 Table 76. Zoetis, Inc. Description and Business Overview
 Table 77. Zoetis, Inc. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 78. Zoetis, Inc. Cattle and Sheep Routine Vaccine Product
 Table 79. Zoetis, Inc. Recent Developments/Updates
 Table 80. Merck & Co., Inc. Company Information
 Table 81. Merck & Co., Inc. Description and Business Overview
 Table 82. Merck & Co., Inc. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 83. Merck & Co., Inc. Cattle and Sheep Routine Vaccine Product
 Table 84. Merck & Co., Inc. Recent Developments/Updates
 Table 85. Bimeda, Inc. Company Information
 Table 86. Bimeda, Inc. Description and Business Overview
 Table 87. Bimeda, Inc. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 88. Bimeda, Inc. Cattle and Sheep Routine Vaccine Product
 Table 89. Bimeda, Inc. Recent Developments/Updates
 Table 90. Elanco Animal Health, Inc. Company Information
 Table 91. Elanco Animal Health, Inc. Description and Business Overview
 Table 92. Elanco Animal Health, Inc. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 93. Elanco Animal Health, Inc. Cattle and Sheep Routine Vaccine Product
 Table 94. Elanco Animal Health, Inc. Recent Developments/Updates
 Table 95. Virbac Company Information
 Table 96. Virbac Description and Business Overview
 Table 97. Virbac Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 98. Virbac Cattle and Sheep Routine Vaccine Product
 Table 99. Virbac Recent Developments/Updates
 Table 100. Ceva Sante Animale Company Information
 Table 101. Ceva Sante Animale Description and Business Overview
 Table 102. Ceva Sante Animale Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 103. Ceva Sante Animale Cattle and Sheep Routine Vaccine Product
 Table 104. Ceva Sante Animale Recent Developments/Updates
 Table 105. CZ Vaccines S.A.U. Company Information
 Table 106. CZ Vaccines S.A.U. Description and Business Overview
 Table 107. CZ Vaccines S.A.U. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 108. CZ Vaccines S.A.U. Cattle and Sheep Routine Vaccine Product
 Table 109. CZ Vaccines S.A.U. Recent Developments/Updates
 Table 110. Indian Immunologicals Ltd. Company Information
 Table 111. Indian Immunologicals Ltd. Description and Business Overview
 Table 112. Indian Immunologicals Ltd. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 113. Indian Immunologicals Ltd. Cattle and Sheep Routine Vaccine Product
 Table 114. Indian Immunologicals Ltd. Recent Developments/Updates
 Table 115. Vaxxinova International BV (EW Group) Company Information
 Table 116. Vaxxinova International BV (EW Group) Description and Business Overview
 Table 117. Vaxxinova International BV (EW Group) Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 118. Vaxxinova International BV (EW Group) Cattle and Sheep Routine Vaccine Product
 Table 119. Vaxxinova International BV (EW Group) Recent Developments/Updates
 Table 120. Jinyu Bio-Technology Company Information
 Table 121. Jinyu Bio-Technology Description and Business Overview
 Table 122. Jinyu Bio-Technology Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 123. Jinyu Bio-Technology Cattle and Sheep Routine Vaccine Product
 Table 124. Jinyu Bio-Technology Recent Developments/Updates
 Table 125. CNBG Company Information
 Table 126. CNBG Description and Business Overview
 Table 127. CNBG Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 128. CNBG Cattle and Sheep Routine Vaccine Product
 Table 129. CNBG Recent Developments/Updates
 Table 130. China Animal Husbandry Industry Co., Ltd. Company Information
 Table 131. China Animal Husbandry Industry Co., Ltd. Description and Business Overview
 Table 132. China Animal Husbandry Industry Co., Ltd. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 133. China Animal Husbandry Industry Co., Ltd. Cattle and Sheep Routine Vaccine Product
 Table 134. China Animal Husbandry Industry Co., Ltd. Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Cattle and Sheep Routine Vaccine Distributors List
 Table 138. Cattle and Sheep Routine Vaccine Customers List
 Table 139. Cattle and Sheep Routine Vaccine Market Trends
 Table 140. Cattle and Sheep Routine Vaccine Market Drivers
 Table 141. Cattle and Sheep Routine Vaccine Market Challenges
 Table 142. Cattle and Sheep Routine Vaccine Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cattle and Sheep Routine Vaccine
 Figure 2. Global Cattle and Sheep Routine Vaccine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Cattle and Sheep Routine Vaccine Market Share by Type: 2025 & 2032
 Figure 4. Modified/ Attenuated Live Vaccines Product Picture
 Figure 5. Inactivated (Killed) Vaccines Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Cattle and Sheep Routine Vaccine Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Cattle and Sheep Routine Vaccine Market Share by Application: 2025 & 2032
 Figure 9. Cattle
 Figure 10. Sheep & Goats
 Figure 11. Global Cattle and Sheep Routine Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Cattle and Sheep Routine Vaccine Market Size (US$ Million), 2021–2032
 Figure 13. Global Cattle and Sheep Routine Vaccine Sales (K Dose), 2021–2032
 Figure 14. Global Cattle and Sheep Routine Vaccine Average Price (US$/Dose), 2021–2032
 Figure 15. Cattle and Sheep Routine Vaccine Report Years Considered
 Figure 16. Cattle and Sheep Routine Vaccine Sales Share by Manufacturers in 2025
 Figure 17. Global Cattle and Sheep Routine Vaccine Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Cattle and Sheep Routine Vaccine Players: Market Share by Revenue in Cattle and Sheep Routine Vaccine in 2025
 Figure 19. Cattle and Sheep Routine Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Cattle and Sheep Routine Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Cattle and Sheep Routine Vaccine Sales Market Share by Country (2021–2032)
 Figure 22. North America Cattle and Sheep Routine Vaccine Revenue Market Share by Country (2021–2032)
 Figure 23. United States Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Cattle and Sheep Routine Vaccine Sales Market Share by Country (2021–2032)
 Figure 26. Europe Cattle and Sheep Routine Vaccine Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Cattle and Sheep Routine Vaccine Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Cattle and Sheep Routine Vaccine Revenue Market Share by Region (2021–2032)
 Figure 34. China Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Cattle and Sheep Routine Vaccine Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Cattle and Sheep Routine Vaccine Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Cattle and Sheep Routine Vaccine Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Cattle and Sheep Routine Vaccine Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Cattle and Sheep Routine Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Cattle and Sheep Routine Vaccine by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Cattle and Sheep Routine Vaccine by Type (2021–2032)
 Figure 54. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Cattle and Sheep Routine Vaccine by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Cattle and Sheep Routine Vaccine by Application (2021–2032)
 Figure 57. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Application (2021–2032)
 Figure 58. Cattle and Sheep Routine Vaccine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners